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• Silver nanoparticles (AgNPs) exhibit unique 
properties due to their size and are becoming 
increasingly prevalent in consumer and industrial 
settings1
• AgNPs are known to induce cytotoxicity within in 
vitro and in vivo environments2
• Correlations have been found between bioresponses
and concentration of internalized NPs3
• The goal was to develop pharmacokinetic profiles for 
experimental AgNPs within a lung (A549) cell model
• Cell Model: Human alveolar cells (A549)
• 10 nm AgNPs: citrate and PVP coatings
• Cytotoxicity: Exposed A549s to AgNPs and analyzed 
viability using MTS assay
• Pharmacokinetics: Exposure of A549s to AgNPs and 
quantified delivered dose via absorbance analysis
Figure 2: Images of 
A549 cells via (A) 
light and (B) 
fluorescence 
microscopy
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Figure 1: Explanation 
of pharmacokinetic 
analysis of AgNPs
Table 1: AgNP Characterization
Figure 3: TEM images of (A) 
citrate and (B) PVP AgNPs
Primary Size (nm)
Water Media Water Media
Citrate 9.3 ± 1.8 22.9 ± 2.3 47.0 ± 2.9 -38.6 ± 1.4 -9.4 ± 0.7
PVP 10.6 ± 1.6 19.1 ± 1.5 35.3 ± 1.8 -22.1 ± 1.1 -10.2 ± 0.6
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Figure 4: Toxicity analysis 
determined AgNP dosage 
for deposition experiments.
Figure 5: Calibration curves correlated AgNP dose 
to peak absorbance
Figure 6: AgNP deposition over a range of time 
exposures from 2-24 hours
AgNPs interact with the A549 cells to a 
high degree within a static environment.
•Using the toxicity analysis, an AgNP dosage of 25 µg/mL was selected.
•A high degree of A549-AgNP association was determined for both experimental particle 
sets, with citrate coated AgNPs having a higher degree of interaction than PVP coated AgNPs. 
•Future work will repeat these analyses at different nanoparticle sizes and under dynamic 
exposure conditions.
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